AZN icon

AstraZeneca

187.03 USD
-2.72
1.43%
At close Updated May 22, 4:00 PM EDT
Pre-market
After hours
187.03
0.00
0%
1 day
-1.43%
5 days
1.96%
1 month
-3.99%
3 months
-8.74%
6 months
104.36%
Year to date
104.25%
1 year
167.38%
5 years
225.44%
10 years
552.81%
 

About: A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Employees: 96,100

0
Funds holding %
of 8,035 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™